| Necrolytic migratory erythema |
| Classification and external resources |
| DiseasesDB |
8833 |
| eMedicine |
derm/168 |
Necrolytic migratory erythema (NME) is a red, blistering rash that spreads across the skin. It particularly affects the skin around the mouth and distal extremities; but may also be found on the lower abdomen, buttocks, perineum, and groin. It is strongly associated with glucagonoma, a glucagon-producing tumor of the pancreas, but is also seen in a number of other conditions including liver disease and intestinal malabsorption.
Contents
- 1 Appearance
- 1.1 Clinical features
- 1.2 Histology
- 2 Cause
- 3 Associated conditions
- 4 See also
- 5 References
Appearance
Clinical features
NME features a characteristic skin eruption of red patches with irregular borders, intact and ruptured vesicles, and crust formation.[1] It commonly affects the limbs and skin surrounding the lips, although less commonly the abdomen, perineum, thighs, buttocks, and groin may be affected.[1] Frequently these areas may be left dry or fissured as a result.[1] All stages of lesion development may be observed synchronously.[2] The initial eruption may be exacerbated by pressure or trauma to the affected areas.[1]
Histology
The histopathologic features of NME are nonspecific[3] and include:[4]
- epidermal necrosis
- subcorneal pustules
- confluent parakeratosis, epidermal hyperlpasia, and marked papillary dermal hyperplasia in a psoriasiform pattern
- angioplasia of papillary dermis
- suppurative folliculitis
The vacuolated, pale, swollen epidermal cells and necrosis of the superficial epidermis are most characteristic.[2] Immunofluorescence is usually negative.[2]
Cause
The etiology of NME is unknown, although various mechanisms have been suggested. These include hyperglucagonemia, zinc deficiency, fatty acid deficiency, hypoaminoacidemia, and liver disease.[2] In addition to the etiology being unknown, the pathogenesis is also unknown.
Associated conditions
William Becker first described an association between NME and glucagonoma in 1942[2][5] and since then, NME has been described in as many as 70% of individuals with a glucagonoma.[6] NME is considered part of the glucagonoma syndrome,[7] which is associated with hyperglucagonemia, diabetes mellitus, and hypoaminoacidemia.[2] When NME is identified in the absence of a glucagonoma, it may be considered "pseudoglucagonoma syndrome".[8] Less common than NME with glucagonoma, pseudoglucagonoma syndrome may occur in a number of systemic disorders:[9]
- Celiac disease
- Ulcerative colitis
- Crohn's disease
- Hepatic cirrhosis
- Hepatocellular carcinoma
- Lung cancer, including small cell lung cancer
- Tumors that secrete insulin- or insulin-like growth factor 2
- Duodenal cancer
See also
- List of cutaneous conditions
References
- ^ a b c d Thiers BH, Sahn RE, Callen JP (2009). "Cutaneous manifestations of internal malignancy". CA – A Cancer Journal for Clinicians 59 (2): 73–98. doi:10.3322/caac.20005. PMID 19258446.
- ^ a b c d e f Pujol RM, Wang CY, el-Azhary RA, Su WP, Gibson LE, Schroeter AL (January 2004). "Necrolytic migratory erythema: clinicopathologic study of 13 cases". International Journal of Dermatology 43 (1): 12–8. doi:10.1111/j.1365-4632.2004.01844.x. PMID 14693015.
- ^ Wilkinson DS (1973). "Necrolytic migratory erythema with carcinoma of the pancreas". Transactions of the St. John's Hospital Dermatological Society 59 (2): 244–50. PMID 4793623.
- ^ Kheir SM, Omura EF, Grizzle WE, Herrera GA, Lee I (July 1986). "Histologic variation in the skin lesions of the glucagonoma syndrome". The American Journal of Surgical Pathology 10 (7): 445–53. doi:10.1097/00000478-198607000-00001. PMID 3014912.
- ^ Becker WS, Kahn D, Rothman S (1942). "Cutaneous manifestations of internal malignant tumors". Archives of Dermatology and Syphilology 45 (6): 1069–1080.
- ^ van Beek AP, de Haas ER, van Vloten WA, Lips CJ, Roijers JF, Canninga-van Dijk MR (November 2004). "The glucagonoma syndrome and necrolytic migratory erythema: a clinical review". Eur. J. Endocrinol. 151 (5): 531–7. doi:10.1530/eje.0.1510531. PMID 15538929.
- ^ Odom, Richard B.; Davidsohn, Israel; James, William D.; Henry, John Bernard; Berger, Timothy G.; Clinical diagnosis by laboratory methods; Dirk M. Elston (2006). Andrews' diseases of the skin: clinical dermatology. Saunders Elsevier. p. 143. ISBN 0-7216-2921-0.
- ^ Marinkovich MP, Botella R, Datloff J, Sangueza OP (April 1995). "Necrolytic migratory erythema without glucagonoma in patients with liver disease". Journal of the American Academy of Dermatology 32 (4): 604–9. doi:10.1016/0190-9622(95)90345-3. PMID 7896950.
- ^ Mignogna MD, Fortuna G, Satriano AR (December 2008). "Small-cell lung cancer and necrolytic migratory erythema". The New England Journal of Medicine 359 (25): 2731–2. doi:10.1056/NEJMc0805992. PMID 19092164.
|
Urticaria and erythema (L50–L54, 695, 708)
|
|
Urticaria
(acute/chronic) |
|
Allergic urticaria
|
- Urticarial allergic eruption
|
|
|
Physical urticaria
|
- Cold urticaria
- Primary cold contact urticaria
- Secondary cold contact urticaria
- Reflex cold urticaria
|
|
- Heat urticaria
- Localized heat contact urticaria
- Solar urticaria
|
|
- Dermatographic urticaria
- Vibratory angioedema
- Pressure urticaria
- Cholinergic urticaria
- Aquagenic urticaria
|
|
|
|
Other urticaria
|
- Acquired C1 esterase inhibitor deficiency
- Adrenergic urticaria
- Exercise urticaria
- Galvanic urticaria
- Schnitzler syndrome
- Urticaria-like follicular mucinosis
|
|
|
Angioedema
|
- Episodic angioedema with eosinophilia
- Hereditary angioedema
|
|
|
| Erythema |
|
Erythema multiforme/
drug eruption
|
- Erythema multiforme minor
- Erythema multiforme major (Stevens–Johnson syndrome, Toxic epidermal necrolysis)
- panniculitis (Erythema nodosum)
- Acute generalized exanthematous pustulosis
|
|
|
Figurate erythema
|
- Erythema annulare centrifugum
- Erythema marginatum
- Erythema migrans
- Erythema gyratum repens
|
|
|
Other erythema
|
- Necrolytic migratory erythema
- Erythema toxicum
- Erythroderma
- Palmar erythema
- Generalized erythema
|
|
|
|
|
|
| Description |
- Anatomy
- Physiology
- Development
|
|
| Disease |
- Infections
- Vesiculobullous
- Dermatitis and eczema
- Papulosquamous
- Urticaria and erythema
- Radiation-related
- Pigmentation
- Mucinoses
- Keratosis, ulcer, atrophy, and necrobiosis
- Vasculitis
- Fat
- Congenital
- Tumors
- nevi and melanomas
- epidermis
- dermis
- Symptoms and signs
|
|
| Treatment |
- Procedures
- Drugs
- disinfectants
- emollients and protectives
- itch
- psoriasis
- other
- Wound and ulcer
|
|
|
|
Paraneoplastic syndromes
|
|
| Endocrine |
- Hypercalcaemia
- SIADH
- Zollinger–Ellison syndrome
- Cushing's syndrome
|
|
| Hematological |
- Granulocytosis
- Multicentric reticulohistiocytosis
|
|
| Neurological |
- Paraneoplastic cerebellar degeneration
- Encephalomyelitis
- Limbic encephalitis
- Opsoclonus
- Polymyositis
- Transverse myelitis
- Lambert–Eaton myasthenic syndrome
- Anti-NMDA receptor encephalitis
|
|
| Musculoskeletal |
- Dermatomyositis
- Hypertrophic osteopathy
|
|
| Mucocutaneous |
| reactive erythema: |
- Erythema gyratum repens
- Necrolytic migratory erythema
|
|
| papulosquamous: |
- Acanthosis nigricans
- Ichthyosis acquisita
- Acrokeratosis paraneoplastica of Bazex
- Extramammary Paget's disease
- Florid cutaneous papillomatosis
- Leser-Trélat sign
- Pityriasis rotunda
- Tripe palms
|
|
| other/ungrouped: |
- Febrile neutrophilic dermatosis
- Pyoderma gangrenosum
- Paraneoplastic pemphigus
|
|
|
|
|
|
| Description |
- Tumor suppressing and oncogenes
- Tumor markers
|
|
| Disease |
- Neoplasms and cancer
- Symptoms and signs
- Paraneoplastic
|
|
| Treatment |
- Drugs
- intracellular chemotherapeutics
- extracellular chemotherapeutics
- adjuvant detoxification
|
|
|
